• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE’s 3Q numbers fall

Article

A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par.

GE’s 3Q numbers fall
A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par. In a financial release Oct. 16, the company reported that revenues fell to $37.8 billion, off 20% compared to the previous year’s third quarter, and earnings fell to $2.5 billion, down 51% from the previous year period.  A breakdown of data regarding financial performance related to healthcare products and services were not immediately available.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.